These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 21288200)
1. New therapeutic advances and perspectives in tumour angiogenesis. Pasquier E; André N Curr Cancer Drug Targets; 2010 Dec; 10(8):877-8. PubMed ID: 21288200 [No Abstract] [Full Text] [Related]
2. Angiogenesis in malignancy. Cao Y Semin Cancer Biol; 2009 Oct; 19(5):277-8. PubMed ID: 19945648 [No Abstract] [Full Text] [Related]
7. Rationale, problems and perspectives in anti-angiogenic therapy. Lorusso G; Dell'Eva R; Vené R; Pfeffer U; Albini A Tumori; 2001; 87(6):S17-9. PubMed ID: 11989611 [No Abstract] [Full Text] [Related]
8. [Anti-angiogenic therapeutic strategies and inhibition of tumor growth]. Bachelot T Ann Pathol; 1999; 19(5 Suppl):S74-5. PubMed ID: 10599459 [No Abstract] [Full Text] [Related]
9. Selective targeting of the tumour vasculature. Chan LS; Daruwalla J; Christophi C ANZ J Surg; 2008 Nov; 78(11):955-67. PubMed ID: 18959693 [TBL] [Abstract][Full Text] [Related]
10. [Neoplasms under control with the help of vascular treatment?]. Laurén J; Alitalo K Duodecim; 2000; 116(7):705-11. PubMed ID: 12078136 [No Abstract] [Full Text] [Related]
11. Angiogenesis inhibitors: what is the clinical future? Verheul HM; Pinedo HM Prog Drug Res; 2005; 63():67-91. PubMed ID: 16265877 [No Abstract] [Full Text] [Related]
12. Targeting coagulation to the tumor microvasculature: perspectives and therapeutic implications from preclinical studies. Narazaki M; Tosato G J Natl Cancer Inst; 2005 May; 97(10):705-7. PubMed ID: 15900035 [No Abstract] [Full Text] [Related]
13. Angiogenesis: What can it offer for future medicine? Cao Y Exp Cell Res; 2010 May; 316(8):1304-8. PubMed ID: 20206162 [TBL] [Abstract][Full Text] [Related]
14. [Anti-angiogenesis drugs as a potential approach in cancer therapy]. Sela B Harefuah; 2000 Oct; 139(7-8):283-9. PubMed ID: 11062974 [No Abstract] [Full Text] [Related]
15. The role of tumor oxygenation in vascular and clinical response to angiogenesis inhibition. Gee MS; Lee WM Adv Exp Med Biol; 2003; 510():1-5. PubMed ID: 12580396 [No Abstract] [Full Text] [Related]
16. Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. Hlatky L; Hahnfeldt P; Folkman J J Natl Cancer Inst; 2002 Jun; 94(12):883-93. PubMed ID: 12072542 [No Abstract] [Full Text] [Related]
17. Advances in the use of angiogenesis inhibitors in cancer. Pinedo HM Cancer J; 2001; 7 Suppl 3():S107-8. PubMed ID: 11779080 [No Abstract] [Full Text] [Related]
18. Targeted Therapies in Cancer - Fourth International Congress. Angiogenesis inhibition. Tawbi H; Agarwala SS IDrugs; 2005 Dec; 8(12):984-6. PubMed ID: 16320129 [No Abstract] [Full Text] [Related]
19. Angiogenesis and current antiangiogenic strategies for the treatment of cancer. Oklu R; Walker TG; Wicky S; Hesketh R J Vasc Interv Radiol; 2010 Dec; 21(12):1791-805; quiz 1806. PubMed ID: 20980167 [TBL] [Abstract][Full Text] [Related]
20. Perspectives on lymphangiogenesis and angiogenesis in cancer. Holopainen T; Bry M; Alitalo K; Saaristo A J Surg Oncol; 2011 May; 103(6):484-8. PubMed ID: 21480240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]